Oxiconazole cream versus ketoconazole cream: A prospective, randomized, double-blind multicentric study in the treatment of tinea cruris;OXICONAZOLE CREME VERSUS KETOCONAZOLE CREME. ETUDE PROSPECTIVE, RANDOMISEE, EN DOUBLE INSU, MULTICENTRIQUE, DANS LE TRAITEMENT DES DERMATOPHYTOSES INGUINOCRURALES

Annales de Dermatologie et de Venereologie

Volumn 123, Issue 8, 1996, Pages 447-452

  Kalis, B ^a   Grosshans, E ^b   Binet, O ^c   Garrel, J B ^d   Grossetete G ^e   Jeanpierre, G ^f   Privat, Y ^g   Sonneck, J M ^d   Souteyrand, P ^h  

^a SERVICE DE DERMATOLOGIE   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c Dermatologie   (France)

^d Service de Dermatologie   (France)

^e Service de Dermatologie   (France)

^f INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^g HÔPITAL NORD   (France)

^h HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FONX; KETOCONAZOLE; OXICONAZOLE; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT; IMIDAZOLE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTACT ALLERGY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SKIN IRRITATION; TINEA CRURIS; TOPICAL DRUG ADMINISTRATION; COMPARATIVE STUDY; DERMATOMYCOSIS; DRUG TOLERANCE; INGUINAL REGION; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ANTIFUNGAL AGENTS; DERMATOMYCOSES; DOUBLE-BLIND METHOD; DRUG TOLERANCE; GROIN; HUMANS; IMIDAZOLES; KETOCONAZOLE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0030331349     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Jegasothy BV, Pakes GE. Oxiconazole nitrate: pharmacology, efficacy, and safety of a new imidazole antifungal agent. Clin Ther 1991;13:126-41.
2. Piérard GE, Piérard-Franchimont C, Arrese Estrada J. Comparative study of the activity and lingering effect of topical antifungals. Skin Pharmacol 1993;5:208-14.
3. Gebhart RJ, Espinel-Ingroff A, Shadomy S. In vitro susceptibility studies with oxiconazole (Ro 13-8996). Chemotherapy 1984;30:244-7.
4. Hiratani T, Uchida K, Yamaguchi H. Oxiconazole nitrate, a new imidazole antimycotic: evaluation of antifungal activity in vitro. Chemotherapy 1984;32:568-84.
5. Polak A. Oxiconazole, a new imidazole derivative. Evaluation of antifungal activity in vitro and in vivo. Arzneimittelforschung 1982;32:17-24.
6. Polak A. Animal experiments for the evaluation of topical antimycotic agents. Experientia 1980;36:494.
7. Polak A. Antifungal activity of four antifungal drugs in the cutaneous retention time test. Sabouraudia Journal of Medical and Veterinary Mycology 1984;22:501-3.
8. Wagner W, Reckers-Czaschka R. Oxiconazol bei Dermatomykosen-ein doppelblinder, randomisierter Therapievergleich mit Bifonazol. Mykosen 1987;30:484-92.
9. Oxiconazole Study Group. Clinical evaluation of oxiconazole in dermatomycosis, comparison with clotrimazole cream in a well-controlled comparative study. Sei Nichi Hifu 1985;47:89-100.
10. Konzelmann M, Graber W. Untersuchung über Wirkung und Verträglichkeit von Oxiconazol-Creme an 100 Mykosepatienten. Acta Ther 1982;8:361-5.
11. Arreaza de Arreaza F, Diaz de Torres E, Briceno Maaz T. Estudio comparative doble ciego de Ro-13-8996 con miconazole en relacion a su eficacia y tolerancia local en pacientes con dermatomicosis [double-blind comparison of oxiconazole with miconazole for efficacy and local tolerance in malades with cutaneous mycoses]. Med Cut ILA 1984;12:57-61.
12. Melis M, Leimer R, Rohde E. Parallel double-blind trial versus miconazole in patients with dermatomycoses. Internal report; 1982 Apr. 2. Report No.: B-77, 356.
13. Machado-Pinto J, Laborne MS. The use of 1 p. 100 oxiconazole cream in the treatment of dermatophytoses. Folha Med 1987;95:381-4.
14. Antifongiques dans les mycoses cutanéo-muqueuses. In : Agence du Médicament, editor. Le bon usage du médicament. Fiches de transparence. Vanves : Comité Français d'Éducation pour la Santé, 1994 Oct. : 87-91.
15. Cooper CR Jr, McGinnis MR, Kemna M, Buchholz MA, Elewski BE. The reservoir effect of oxiconazole nitrate, 1 p. 100 cream (OXC) in protecting against Trichophyton mentagrophytes infection. Poster of the Fifty Fourth AAD Annual Meeting: 1996 Feb. 10-15; Washington DC. American Academy of Dermatology, 1996.
16. Jeanmougin M, editor. Actualités thérapeutiques. Kétoderm® crème, kétoconazole. Mise au point [numéro hors série]. Meudon : Publications Médicales Internationales, 1991. JAMA [Ed Fr] 1991 Sep.(Suppl):1-23.
17. rd ed. Paris : éditions Varia 1991:51-57.
18. Parisis NG, Leimer R, Rohde E. Randomized double-blind trial versus miconazole cream in patients with dermatomycoses. Internal report; 1981 Jul. 17. Report No.: B-90, 296.
19. Parissis N, Noutsis C, Koumantaki E, Stratigos J. Comparative clinical studies with the imidazolyl derivative Ro 13-8996, tolnaftate, and miconazole. Proceedings of the 12th Internat. Congress of Chemotherapy: 1981; Florence. Current Chemotherapy and Immunotherapy 1981;2:1025-7.
20. Gip L. Comparison of oxiconazole (Ro 13-8996) and econazole in dermatomycoses. Mykosen 1983;27:295-302.
21. Ellis CN, Gammon WR, Goldfarb MT, Griffin TB, Jegasothy BV, Kamm AR et al. A placebo-controlled evaluation of once-daily versus twice-daily oxiconazole nitrate (1 p. 100) cream in the treatment of tinea pedis. Curr Ther Res 1989;46:269-76.
22. Lebwohl M, Rex IH, Tschen E, Tharp MD, Ward WO, Whitmore C. Oxiconazole nitrate cream, 1 p. 100, once or twice daily in the treatment of tinea pedis [abstract]. Clin Res 1989;32:662.
23. Dooms-Goossens A, Matura M, Drieghe J, Degreef H. Contact allergy to imidazoles used as antimycotic agents. Contact Dermatitis 1995;33:73-7.
24. Savin RC, Horwitz SN. Double-blind comparison of 2 p. 100 ketoconazole cream and placebo in the treatment of tinea versicolor. J Am Acad Dermatol 1986;15:500-3.
25. Guidetti MS, Vincenzi C, Guerra L, Tosti A. Contact dermatitis due to imidazole antimycotics. Contact Dermatitis 1995;33:282.